Literature DB >> 11129470

Regression models for disease prevalence with diagnostic tests on pools of serum samples.

S Vansteelandt1, E Goetghebeur, T Verstraeten.   

Abstract

Whether the aim is to diagnose individuals or estimate prevalence, many epidemiological studies have demonstrated the successful use of tests on pooled sera. These tests detect whether at least one sample in the pool is positive. Although originally designed to reduce diagnostic costs, testing pools also lowers false positive and negative rates in low prevalence settings and yields more precise prevalence estimates. Current methods are aimed at estimating the average population risk from diagnostic tests on pools. In this article, we extend the original class of risk estimators to adjust for covariates recorded on individual pool members. Maximum likelihood theory provides a flexible estimation method that handles different covariate values in the pool, different pool sizes, and errors in test results. In special cases, software for generalized linear models can be used. Pool design has a strong impact on precision and cost efficiency, with covariate-homogeneous pools carrying the largest amount of information. We perform joint pool and sample size calculations using information from individual contributors to the pool and show that a good design can severely reduce cost and yet increase precision. The methods are illustrated using data from a Kenyan surveillance study of HIV. Compared to individual testing, age-homogeneous, optimal-sized pools of average size seven reduce cost to 44% of the original price with virtually no loss in precision.

Mesh:

Year:  2000        PMID: 11129470     DOI: 10.1111/j.0006-341x.2000.01126.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  36 in total

1.  binGroup: A Package for Group Testing.

Authors:  Christopher R Bilder; Boan Zhang; Frank Schaarschmidt; Joshua M Tebbs
Journal:  R J       Date:  2010-12-01       Impact factor: 3.984

2.  Bayesian regression for group testing data.

Authors:  Christopher S McMahan; Joshua M Tebbs; Timothy E Hanson; Christopher R Bilder
Journal:  Biometrics       Date:  2017-04-12       Impact factor: 2.571

3.  On latent-variable model misspecification in structural measurement error models for binary response.

Authors:  Xianzheng Huang; Joshua M Tebbs
Journal:  Biometrics       Date:  2008-09-29       Impact factor: 2.571

4.  Positing, fitting, and selecting regression models for pooled biomarker data.

Authors:  Emily M Mitchell; Robert H Lyles; Enrique F Schisterman
Journal:  Stat Med       Date:  2015-04-06       Impact factor: 2.373

5.  Semiparametric regression models for a right-skewed outcome subject to pooling.

Authors:  Emily M Mitchell; Robert H Lyles; Amita K Manatunga; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2015-03-03       Impact factor: 4.897

6.  Regression models for group testing data with pool dilution effects.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biostatistics       Date:  2012-11-28       Impact factor: 5.899

7.  Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments.

Authors:  Christopher S McMahan; Alexander C McLain; Colin M Gallagher; Enrique F Schisterman
Journal:  Biom J       Date:  2016-03-01       Impact factor: 2.207

8.  Regression for skewed biomarker outcomes subject to pooling.

Authors:  Emily M Mitchell; Robert H Lyles; Amita K Manatunga; Michelle Danaher; Neil J Perkins; Enrique F Schisterman
Journal:  Biometrics       Date:  2014-02-12       Impact factor: 2.571

9.  Group testing regression models with fixed and random effects.

Authors:  Peng Chen; Joshua M Tebbs; Christopher R Bilder
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

10.  Group testing regression models with dilution submodels.

Authors:  Md S Warasi; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Stat Med       Date:  2017-08-30       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.